TSE:OTEX
Open Text (OTEX.TO)
Financials 
Technical Analysis 
Aug 13, 2026, 12:00 amThis summary was created by AI, based on 22 opinions in the last 12 months.
Open Text (OTEX) is experiencing significant investor skepticism due to various factors, primarily associated with the impact of artificial intelligence (AI) on traditional software models. While some analysts see potential value in the company's low price-to-earnings (PE) ratio of 5.2x and a 4% dividend yield, others express concern over the lack of organic growth and the failure of acquisitions to boost operational performance. The stock is currently positioned below important resistance at $35, and many recommendations suggest either waiting for better entry points or looking to invest elsewhere. The recent management changes add to uncertainties about its direction, leading experts to recommend caution with investments in Open Text. Overall, the sentiment remains mixed, reflecting both potential for recovery and significant risks ahead.
James Telfser
It's trading near 52-week highs, though held back a little compared to its peers. This will change given their focus on the cloud and maybe an acqusition. They will grow around 5% organically. They will buy back a lot of stock. Their Google partnership in the cloud holds great potential. Trades at 11x EBITDA vs. 17x peers. (Analysts’ price target is $59.97)
James Telfser
Fine company. They buy companies to grow, paid by excess free cash flow. Low valuation, too. There's good growth; they just struck a partnership with Google.
John ZechnerTheir partnership with Google and Mastercard He's followed this many years and once owned it. Their partnership with Google is excellent; Google is number three in the cloud space. This partnership may accelerate OTEX's organic growth which has traditionally been tepid and done through acqusitions. This trades at 14x earnings when the software space is much higher. He likes OTEX.
Norman Levine
An underloved Canadian software stock that is now focusing on the cloud, reducing lumpiness in their business. Trading at 11x EBITDA vs. peers at 17-18x. They close the valuation gap. (Analysts’ price target is $60.91)
James Telfser
James Hodgins'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20scale(-1,%201)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
